Abstract
In this issue of Cell Stem Cell, Zaruba et al. (2009) describe a pharmacoregenerative strategy for myocardial infarction. Using G-CSF to release progenitors from bone marrow and protease inhibition to prevent degradation of the homing signal, SDF-1, the authors achieve increased recruitment to the heart and improved heart function.
MeSH terms
-
Animals
-
Cardiovascular System / metabolism
-
Cell Movement / physiology
-
Chemokine CXCL12 / metabolism*
-
Dipeptidyl Peptidase 4 / metabolism
-
Granulocyte Colony-Stimulating Factor / therapeutic use*
-
Hematopoietic Stem Cell Mobilization
-
Mice
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / physiopathology
-
Neovascularization, Physiologic*
-
Receptors, CXCR4 / metabolism*
-
Regeneration / physiology*
Substances
-
CXCR4 protein, mouse
-
Chemokine CXCL12
-
Cxcl12 protein, mouse
-
Receptors, CXCR4
-
Granulocyte Colony-Stimulating Factor
-
Dipeptidyl Peptidase 4